Schedule 13D ownership disclosure

Fennec Pharmaceuticals Inc

Security class unavailable · CUSIP: 31447P100

Event date: 2018-05-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-18-003889
Form type
SC 13D/A
Filer
FENNEC PHARMACEUTICALS INC.
CIK
CIK 1211583
Filed
May 18, 2018
Reporting period
May 17, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub